✨ Free AI Report
Capricor Therapeutics, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Capricor Therapeutics, Inc.
Research Preview

Capricor Therapeutics, Inc.: Business Overview, Financials & Competitive Analysis

Capricor Therapeutics is a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, with lead product Deramiocel, an allogeneic cardiac-derived cell therapy in late-stage ...

Analyst-debate audio for Capricor Therapeutics, Inc.

AskCyborg analysts argue the bull and bear cases for Capricor Therapeutics, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Capricor Therapeutics, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
7/ 10Strong

Cyborg Score thesis

Clinical validation of DMD therapy with regulatory momentum creates value inflection potential for orphan drug...

Read the full analyst-debate transcript →
Industry Biotechnology - Regenerative Medicine & Cell Therapy
1 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Capricor Therapeutics, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Capricor Therapeutics, Inc. Overview

Pro stress-test →

Capricor Therapeutics is a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, with lead product Deramiocel, an allogeneic cardiac-derived cell therapy in late-stage development for Duchenne muscular dystrophy (DMD). The company is advancing toward regulatory approval with a clear path through FDA review and significant clinical validation.

Strategic Profile

Pro stress-test →

Deramiocel has demonstrated potent immunomodulatory and anti-fibrotic effects in helping preserve cardiac and skeletal muscle function in DMD. Capricor is leveraging its proprietary StealthX™ platform in preclinical development focused on vaccinology and targeted delivery of oligonucleotides, proteins, and small-molecule therapeutics, positioning the company as a multi-pipeline platform player in regenerative medicine.

Competitive Landscape

Pro stress-test →

Capricor operates in the rare disease and regenerative medicine space, competing against other DMD therapeutic developers. The company's cell therapy platform with demonstrated Phase 3 clinical efficacy differentiates it from small molecule and gene therapy approaches. Limited direct competitors with validated Phase 3 cell therapies for DMD at comparable development stage.

Industry Context

Capricor Therapeutics, Inc. operates in Biotechnology - Regenerative Medicine & Cell Therapy.

Key facts

Headquarters: San Diego, United States

What the analysts stress-tested

The top findings that survived the multi-agent debate for Capricor Therapeutics, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Capricor Therapeutics, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Gene therapies and small molecule therapeuticsAlternative modalities for DMD treatment→

Compare Capricor Therapeutics, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Capricor Therapeutics, Inc. operates in Biotechnology - Regenerative Medicine & Cell Therapy. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology - Regenerative Medicine & Cell Therapy research →
NEW · MCP server

Ask your AI assistant about Capricor Therapeutics, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Capricor Therapeutics, Inc. and its top competitor on Cyborg Score”
“What did Capricor Therapeutics, Inc. do this quarter?”
“Is Capricor Therapeutics, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Capricor Therapeutics, Inc. do?+
Capricor Therapeutics is a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, with lead product Deramiocel, an allogeneic cardiac-derived cell therapy in late-stage ...
What is Capricor Therapeutics, Inc.'s Cyborg Score?+
Capricor Therapeutics, Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Capricor Therapeutics, Inc.'s main competitors?+
Named competitors include Gene therapies and small molecule therapeutics. The full competitive landscape is in the AskCyborg report.
How can I get the full Capricor Therapeutics, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Capricor Therapeutics, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Capricor Therapeutics, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.